iMDK Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

iMDK is a small molecule inhibitor used to bind to midkine (MDK), a heparin binding growth factor that is expressed in malignant tumors.

iMDK Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

iMDK Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	32281	58
TargetMol Chemicals Inc.		support@targetmol.com	United States	38665	58
Aladdin Scientific		tp@aladdinsci.com	United States	52924	58
Angel Pharmatech, Ltd.	17317130613	3358272972@qq.com	China	3262	58
Shanghai EFE Biological Technology Co., Ltd.	021-65675885 18964387627	info@efebio.com	China	9803	58
Beijing Solarbio Science & Tecnology Co., Ltd.	010-50973130 17801761073	3193328036@qq.com	China	29763	68
Suzhou youruike Chemical Pharmaceutical Technology Co., Ltd	15317229551	15151849396@163.com	China	1000	58
MedBioPharmaceutical Technology Inc	021-69568360 18916172912	order@med-bio.cn	China	8140	58
Changzhou Furuisi Biotechnology Co., Ltd	0519-85524369	3477467573@qq.com	China	8617	58
Bide Pharmatech Ltd.	400-1647117 13681763483	product02@bidepharm.com	China	62321	58

---

• iMDK
• 3-[2-(4-Fluoro-benzyl)-imidazo[2,1-b]thiazol-6-yl]-chromen-2-one
• 2H-1-Benzopyran-2-one, 3-[2-[(4-fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-
• inhibit,iMDK,midkine,factor,PI3K,NSCLC,growth,Inhibitor,Phosphoinositide 3-kinase,MDK
• 3-[2-[(4-Fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-2H-1-benzopyran-2-one
• 3-(2-(4-Fluorobenzyl)imidazo[2,1-b]thiazol-6-yl)-2H-chromen-2-one
• iMDK, 10 mM in DMSO
• 881970-80-5